64
Participants
Start Date
October 21, 2020
Primary Completion Date
February 27, 2023
Study Completion Date
February 27, 2023
TAK-071
TAK-071 tablet.
Placebo
TAK-071 placebo-matching tablet.
University of Rochester Medicine - Movement Disorders Unit, Rochester
University of Philadelphia, Philadelphia
Meridian Clinical Research, Norfolk
Medical University of South Carolina - PPDS, Charleston
Augusta University, Augusta
PPD Phase 1 Clinic, Orlando
Infinity Clinical Research, LLC, Sunrise
USF Medical Clinic, Tampa
Neurology Diagnostics, Inc. - ERG - PPDS, Dayton
Indiana University Health Neuroscience Center, Indianapolis
Quest Research Institute - Hunt - PPDS, Farmington Hills
Park Nicollet Health Services, Golden Valley
Feinberg School of Medicine Northwestern University, Chicago
Baylor College of Medicine, Houston
Central Texas Neurology, Round Rock
Rocky Mountain Movement Disorders Center, Englewood
Cedars Sinai Medical Center, Los Angeles
University of California Irvine Medical Center, Irvine
Collaborative Neuroscience Network, LLC, Garden Grove
Evergreen Hospital Medical Center, Kirkland
Inland Northwest Research, Spokane
Lead Sponsor
Michael J. Fox Foundation for Parkinson's Research
OTHER
Takeda
INDUSTRY